Clinical Trial: Treatment of Orthostatic Intolerance in Patients With Parkinson's Disease Using Midodrine

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional




Official Title: Treatment of Orthostatic Intolerance in Patients With Parkinson's Disease Using Midodrine

Brief Summary: This study will evaluate whether treatment with the α1-agonist, midodrine, reduces subjective orthostatic lightheadedness as measured by the Non-Motor Symptoms Scale for Parkinson's Disease (NMSS) questionnaire, in patients with (positive control group, OH) or without documented orthostatic hypotension(orthostatic intolerance, OI). It will also demonstrate the effect of treatment with an α1-agonist, midodrine, on beat-to-beat blood pressure and heart rate response during Valsalva maneuver (measured by Continuous Non-invasive Arterial Pressure, CNAP) in patients with OI or OH and evaluate the relationship to symptom improvement.